Select a community
Mood Conditions including Depression, Anxiety, Bipolar, OCD, and PTSD
Find out more about the PatientsLikeMe
Mood Conditions Community
Home > Community Treatment Reports > Atenolol Treatment Report
What is Atenolol?

Atenolol, a beta blocker, is used to treat hypertension, alone or in combination with other agents. Off label use for acute alcohol withdrawal, certain cardiac arrhythmias, and prevention of migraine headache.

Side Effects

Side effects as an overall problem

Severe
0 0%
Moderate
2 20%
Mild
2 20%
None
6 60%

Most commonly reported side effects

Leg pain (both)
1 10%
weak, tired slow heart rate
1 10%
Cold hands and feet
1 10%
Shortness of breath
1 10%
Dizziness
1 10%
Fatigue
1 10%
  • Mild
  • Moderate
  • Severe

Dosages

  0.5mg/mL as needed 0.5 mg daily 0.5 mg/mL daily 12 mg daily 25 mg daily 50 mg daily 100 mg daily
  1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 10 Number of Patients: 10 18 Number of Patients: 18 7 Number of Patients: 7  

Stop Reasons

Why Patients Stopped Taking Atenolol (multiple reasons could be selected)
Reason # Patients Percentage of patients
Doctor's advice
2 67% Doctor's advice: 67%
Personal research
1 33% Personal research: 33%
Other
1 33% Other: 33%
Not indicated
1 33% Not indicated: 33%

See all 3 patients who’ve stopped taking Atenolol

Currently Taking Atenolol

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
1
8
5
10

Stopped Taking Atenolol

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
1
0
1
1
0

Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Always
8 80%
Usually
2 20%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
1 10%
Somewhat
0 0%
A little
1 10%
Not at all
8 80%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
8 80%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 23, 2009.